Transgene Announces Upcoming Investor Meetings
18 Mars 2024 - 5:45PM
UK Regulatory
Transgene Announces Upcoming Investor Meetings
Strasbourg, March 18, 2024 - 05:45 pm CET
TRANSGENE (Paris: TNG) today
announces that Management will participate in several investor
events in the upcoming months, as set out below.
- Investor Access Event (Paris, France): April
5, 2024,
- Van Lanschot Kempen Life Sciences Conference
(Amsterdam, Netherlands): April 16, 2024,
- Oddo BHF Nextcap Forum (virtual): June 6,
2024.
Contacts
Transgene:
Lucie Larguier
+33 (0)3 88 27 91 04
investorrelations@transgene.fr |
Media:
MEDiSTRAVA Consulting
Frazer Hall/Sylvie Berrebi
+44 (0)203 928 6900
transgene@medistrava.com |
About Transgene
Transgene (Euronext: TNG) is a biotechnology
company focused on designing and developing targeted
immunotherapies for the treatment of cancer. Transgene’s programs
utilize viral vector technology with the goal of indirectly or
directly killing cancer cells.
The Company’s clinical-stage programs consist of a portfolio of
therapeutic vaccines and oncolytic viruses:
TG4050, the first individualized therapeutic vaccine based on the
myvac® platform, TG4001 for the treatment of HPV-positive
cancers, as well as TG6050 and BT-001, two oncolytic viruses based
on the Invir.IO® viral backbone.
With Transgene’s myvac® platform, therapeutic vaccination
enters the field of precision medicine with a novel immunotherapy
that is fully tailored to each individual. The myvac®
approach allows the generation of a virus-based immunotherapy that
encodes patient-specific mutations identified and selected by
Artificial Intelligence capabilities provided by its partner
NEC.
With its proprietary platform Invir.IO®, Transgene is building on
its viral vector engineering expertise to design a new generation
of multifunctional oncolytic viruses.
Additional information about Transgene is available at:
www.transgene.fr
Follow us on social media: X (formerly Twitter): @TransgeneSA –
LinkedIn: @Transgene
- 20240318-Transgene-investor-meetings-spring-2024-EN
Transgene (LSE:0OCQ)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Transgene (LSE:0OCQ)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024